Literature DB >> 23760630

Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.

Zsolt Mezei1, Laszlo Olah, Laszlo Kardos, Reka Katalin Kovacs, Laszlo Csiba, Tunde Csepany.   

Abstract

Demyelination in multiple sclerosis (MS) may cause damage to the vegetative nervous system. Our objective was to examine cerebral autoregulation assessed via blood pressure and cerebral blood flow velocity fluctuations during head-up tilt table testing. We also investigated the effects of high-dose intravenous corticosteroid treatment. Transcranial Doppler registration of middle cerebral artery blood flow velocity and continuous blood pressure and heart rate monitoring were performed at rest and during tilt table testing in 30 MS patients. Ten age-matched healthy subjects were also examined as controls. Correlations between mean arterial blood pressure (MBP) and cerebral blood flow velocity (CBF) fluctuations were averaged, yielding the correlation coefficient index Mx. For a subgroup of 11 patients with acute exacerbations, results were also evaluated before and after methylprednisolone treatment (1 g/day intravenously for 5 days). No significant differences in the autoregulatory indices were seen between patients and controls, or between pre- and post-steroid results. Modeling CBF velocity changes associated with a 1-mmHg increase in MBP, significant differences (p < 0.05) were detected in patients vs. controls, and also after vs. before steroid administration. We conclude that cerebrovascular autoregulation impairments are detectable in early phase MS. Corticosteroid treatment has a significant effect on hemodynamic changes in acute exacerbations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760630     DOI: 10.1007/s00415-013-6977-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

1.  Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance.

Authors:  P Flachenecker; A Wolf; M Krauser; H P Hartung; K Reiners
Journal:  J Neurol       Date:  1999-07       Impact factor: 4.849

2.  Autonomic neural control of dynamic cerebral autoregulation in humans.

Authors:  Rong Zhang; Julie H Zuckerman; Kenichi Iwasaki; Thad E Wilson; Craig G Crandall; Benjamin D Levine
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

3.  Dynamic cerebral autoregulation and monitoring cerebral perfusion.

Authors:  Niels H Secher; Johannes J van Lieshout
Journal:  Hypertension       Date:  2010-06-14       Impact factor: 10.190

4.  Dynamic cerebral autoregulation: different signal processing methods without influence on results and reproducibility.

Authors:  Erik D Gommer; Eri Shijaku; Werner H Mess; Jos P H Reulen
Journal:  Med Biol Eng Comput       Date:  2010-11-04       Impact factor: 2.602

Review 5.  Mechanisms of glucocorticoids in the control of neuroinflammation.

Authors:  N Schweingruber; S D Reichardt; F Lühder; H M Reichardt
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

Review 6.  Rapid vascular effects of steroids - a question of balance?

Authors:  Ross D Feldman; Robert Gros
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

Review 7.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

8.  Progressive impairment of autonomic control of heart rate in patients with multiple sclerosis.

Authors:  Darija Mahovic; Nenad Lakusic
Journal:  Arch Med Res       Date:  2007-04       Impact factor: 2.235

9.  Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.

Authors:  Khalil Kanjwal; Beverly Karabin; Yousuf Kanjwal; Blair P Grubb
Journal:  Int J Med Sci       Date:  2010-03-11       Impact factor: 3.738

Review 10.  Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis.

Authors:  Peter Flachenecker
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

View more
  4 in total

1.  Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.

Authors:  Nicholas A Hubbard; Monroe Turner; Joanna L Hutchison; Austin Ouyang; Jeremy Strain; Larry Oasay; Saranya Sundaram; Scott Davis; Gina Remington; Ryan Brigante; Hao Huang; John Hart; Teresa Frohman; Elliot Frohman; Bharat B Biswal; Bart Rypma
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-09       Impact factor: 6.200

2.  Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial.

Authors:  Regina Berkovich; Rohit Bakshi; Lilyana Amezcua; Robert C Axtell; Steven Y Cen; Shahamat Tauhid; Mohit Neema; Lawrence Steinman
Journal:  Ther Adv Neurol Disord       Date:  2016-10-19       Impact factor: 6.570

Review 3.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

4.  Cerebral blood flow changes during tilt table testing in healthy volunteers, as assessed by Doppler imaging of the carotid and vertebral arteries.

Authors:  C Linda M C van Campen; Freek W A Verheugt; Frans C Visser
Journal:  Clin Neurophysiol Pract       Date:  2018-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.